---
category: trading
circular_id: f8083d7ab7fc4f7d
date: '2025-12-02'
description: Revised settlement calendar for the takeover offer of J.B. Chemicals
  & Pharmaceuticals Limited conducted from November 18, 2025 to December 1, 2025,
  with updated obligation download and settlement dates.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={482C8A1D-CA21-42AC-BFA0-5D89114BF7C6}&noticeno=20251202-23&dt=12/02/2025&icount=23&totcount=35&flag=0
impact: medium
impact_ranking: medium
importance_ranking: medium
justification: Affects settlement timelines for members and custodians involved in
  the J.B. Chemicals takeover offer, requiring updated obligation download and settlement
  procedures.
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20251202-23&attachedId=
processing:
  attempts: 1
  content_hash: e8ce35a420b1409b
  processed_at: '2025-12-02T12:51:09.688605'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-12-02T10:44:28+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={482C8A1D-CA21-42AC-BFA0-5D89114BF7C6}&noticeno=20251202-23&dt=12/02/2025&icount=23&totcount=35&flag=0
severity: medium
source: bse
stocks:
- JBCHEMPHARMA
tags:
- takeover
- settlement
- acquisition-window
- jbchempharma
- revised-schedule
- rms
- early-pay-in
title: Revised Settlement Schedule for J.B. Chemicals & Pharmaceuticals Takeover Offer
---

## Summary

BSE has issued a revised settlement schedule for the Offer to Buy (Acquisition Window - Takeover) of J.B. Chemicals & Pharmaceuticals Limited. The bidding period ran from November 18, 2025 to December 1, 2025, with the revised obligation download date set for December 4, 2025 and settlement date of December 5, 2025. This notice updates the previous schedule announced in Notice No. 20251113-42.

## Key Points

- Settlement Type: Takeover (Settlement No. 2025121)
- Bid Period: November 18, 2025 to December 1, 2025
- Revised Obligation Download: December 4, 2025
- Revised Settlement Date: December 5, 2025
- Demat shares must be delivered exclusively through Early Pay-in of Shares mechanism
- Early Pay-in facility available in both depositories
- Market Type "Takeover" and Settlement No. 2025121 must be specified in depository system
- Client-wise stamp duty charges available in MBRSTD_OTB_CM_mmm_SettNo file

## Regulatory Changes

No new regulatory changes. The notice follows the revised guidelines for mechanism of acquisition of shares through Stock Exchange as per Notice No. 20200528-32 dated May 28, 2020.

## Compliance Requirements

- **Members/Custodians**: Must deliver demat shares only through Early Pay-in of Shares mechanism
- **Members/Custodians**: Must use Market Type "Takeover" and Settlement No. 2025121 in depository system entries
- **Members**: Must refer to MBRSTD_OTB_CM_mmm_SettNo file for client-wise stamp duty charges
- **Members/Custodians**: Should refer to Notice No. 20200528-32 dated May 28, 2020 for settlement procedures under revised acquisition guidelines

## Important Dates

- **Bid Start Date**: November 18, 2025
- **Bid End Date**: December 1, 2025
- **Revised Obligation Download**: December 4, 2025
- **Revised Settlement Date**: December 5, 2025
- **Notice Date**: December 2, 2025

## Impact Assessment

**Operational Impact**: Members and custodians participating in the J.B. Chemicals takeover offer must adjust their settlement workflows to align with the revised dates. The two-day extension for obligation download and settlement provides additional time for processing.

**Market Impact**: Limited market-wide impact as this affects only parties involved in the specific takeover offer for J.B. Chemicals & Pharmaceuticals Limited. The mandatory use of Early Pay-in mechanism ensures smoother settlement and reduces risk.

**Process Impact**: Participants must ensure proper reference to Settlement No. 2025121 and Market Type "Takeover" in all depository system transactions to avoid settlement failures. Contact available through ICCL Help Desk (022-69158590/45720490/45720690, iccl.helpdesk@icclindia.com) for clarifications.